AMBERE RIGGS: Open Payments
NPI 1487207924 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 13 payments from 7 companies in 2025. Trend: 2023 $48 · 2024 $167 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $111 |
| Philips North America LLC | 2 | $44 |
| Novo Nordisk Inc | 1 | $26 |
| ABIOMED | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $12 |
Products named: AVEIR, Ambulatory Monitoring & Diagnostics Undivided, Wegovy, VERQUVO, LEQVIO, LifeVest.
Industry payments across MS — which companies pay providers there.
